News

Seoul St. Mary’s Hospital, which was established in 2009 and part of the Catholic Medical Centre (CMC), recently announced that it has been operating a digital pathology system that aids in the diagnosis of cancer since last month. The system, known as the Philips IntelliSite Pathology Solution, allows the hospital’s pathology team to obtain accurate diagnosis results through a digitalised method. The system automatically creates, visualises, and manages digital pathology images based on an image management system, including a slide scanner, a server, a storage device, and a viewer. The digitalisation of pathology images will allow pathologists to make diagnoses through computer monitors. In addition, clinicians from other departments in the hospital can digitally access the digital pathology images easily, increasing efficiency and opening more opportunities for collaboration. THE LARGER TREND In 2017, the Philips received FDA clearance to market its IntelliSite Pathology Solution for primary diagnostic use in the US. The solution also received the green light from South Korea’s Ministry of Food and Drug Safety in June 2018. In the US, Mount Sinai and LabCorp announced last month that they would collaborate to establish the Mount Sinai Digital and Artificial Intelligence-Enabled Pathology Centre of Excellence. LabCorp, has implemented the Philips IntelliSite Pathology Solution in four of its laboratories and plans to introduce it to additional laboratories, will use its experience and expertise to lead the integration of digital pathology into clinical practice across Mount Sinai’s hospitals. A report by Frost & Sullivan in February 2019 “sees wider use and better management of the clinical datasets owned by major medical institutions as a major boon for developers of digital pathology tech.” ON THE RECORD “Through the establishment of a digital pathology system, we will be able to shift from previous ways of interpreting analog microscopic image to a more digitalised technology, which will boost efficiency and productivity,” said Lee Youn-soo, a professor at St. Mary’s Department of Pathology in a statement.

White's areas of focus at the agency included the Shared Nationwide Interoperability Roadmap, the recently proposed information blocking rules.

At North Suburban Cardiology Associates in Stoneham, Massachusetts, there were several gaps in the group’s ambulatory ECG monitoring capability. Holter monitors, event monitors and mobile cardiac telemetry were on different platforms. Using different systems meant some operational friction during ordering and patient set-up as well as different platforms for analysis and reporting. Operational friction “Our Holter monitors would be downloaded in the office, then the raw data would be analyzed by a technician who worked remotely, and finally the interpreting physician would log in to that system, generate and finalize the report, and then move it into our EHR,” said Dr. Michael Mazzini, a partner at North Suburban Cardiology Associates and an assistant professor of medicine at Tufts University School of Medicine. Event monitors and mobile cardiac telemetry would be hooked up in the office, with all data management handled externally. Paper reports then were faxed to the office, reviewed and finalized by one of the group’s physicians, and again moved into the EHR. “Another issue was having immediate access to all the data with mobile cardiac telemetry rather than just getting daily summary reports,” Mazzini said. “I always wanted to have something closer to the full disclosure data that one would get with telemetry in hospital.” To help solve the problems it was facing, North Suburban Cardiology Associates turned to the MoMe Kardia wearable cardiac monitor from InfoBionic in Lowell, Massachusetts. InfoBionic offers the ability to use Holter, event monitoring and mobile cardiac telemetry all within the same device. A big step forward in efficiency “This means a uniform set-up process for all patients as well as the same analysis and reporting workflow – that alone was a big step forward in efficiency,” Mazzini explained. “Moreover, you can switch between modalities on the fly. If a Holter is non-diagnostic, for example, we can switch to event or MCT without having to bring the patient back and hook them up to a different device.” In terms of data analysis, the group now is able to efficiently manage all the data within its office. For Holter monitors, that allowed cost savings. For both event monitoring and mobile cardiac telemetry, it meant that the group had access to the data as soon as it wanted it. "Once the patient is being monitored, the ordering physician is then able to handle the rest of the monitoring process through the web-based user interface." Dr. Michael Mazzini, North Suburban Cardiology Associates “And for MCT, we now had access to near-real-time full disclosure of data – this is not a feature of other MCT platforms,” Mazzini said. “The user interface is also very intuitive in terms of both set-up and analysis. We have been able to very quickly onboard all the physicians as well as staff, and everyone is pretty facile with the system.” Setting patients up When a physician determines that a patient requires ambulatory ECG monitoring, one of the group’s medical assistants registers the patient with the device and goes through showing that patient how to use the device. “Once the patient is being monitored, the ordering physician is then able to handle the rest of the monitoring process through the web-based user interface,” Mazzini explained. “For MCT, that means that if needed, we can log in at any time to see how the patient is doing, or allow the system itself to alert us to any arrhythmias that we would be interested in.” At the end of the monitoring period, a standardized report is generated. “What is really nice is that we can use the full disclosure feature for MCT to scroll through all the data – even segments that we might not otherwise have access to in other systems, like onset and offset of supraventricular tachycardia,” Mazzini said. “As an electrophysiologist, I find this feature to be especially helpful.” Multiple, non-integrated ambulatory ECG systems Mazzini offers some advice for other cardiac caregivers considering this technology. “The technology is highly scalable – we run a small but busy office with six cardiologists and a nurse practitioner,” he said. “This platform is one that could be used efficiently in a solo practice as well as a large integrated or academic practice. “My advice would be to take a minute to assess one’s own ambulatory ECG platforms,” he added. “if they are using multiple, non-integrated ambulatory ECG systems, they definitely have an opportunity for improvement.” Twitter: @SiwickiHealthIT Email the writer: bill.siwicki@himssmedia.com

The health system will use Azure as its preferred platform and will deploy emerging technologies from Microsoft at an affiliated hospital facility in Seattle, near the technology giant’s Redmond headquarters.

There's continued resistance from many pharmaceutical industry executives, who think it's never possible to safely store sensitive data in the cloud.

Pay for performance models continue to experience a hard time, especially those that try to leverage capitated payment schemes to reach the ‘triple aim’ of improved population health, enhanced patient care, and cost reduction. 

As more than 200 health systems have signed on with the patient empowerment movement, population health, patient safety and quality improvement gains are apparent.

At UMass Memorial Health Care, an audit found a vendor security problem. Here’s how the health system bolstered its security while achieving a 594% annual ROI.

A Frost & Sullivan report predicts that as many as 45% of ORs will be integrated with intelligent technologies within the next four years to improve the precision and predictability of surgical services.